Skip to main content
. 2022 May 17;12:8230. doi: 10.1038/s41598-022-12301-6

Figure 8.

Figure 8

Molecular characteristics of IGSPP subgroups. (A, B) GSEA enrichment analysis in the IGSPP high-risk group (p < 0.05). (C) GSEA enrichment analysis in the IGSPP low-risk group (p < 0.05). (D) Gene mutations of patients within the IGSPP high-risk group. (E) Gene mutations of patients within the IGSPP low-risk group. (F) Correlation between the TMB and IGSPP score. (G) Correlation between the TMB and OS in patients with LUAD.